Skip to content

Jonasz Jeremiasz Weber

  • PhD
  • Postdoctoral Researcher
  • Universitatsklinikum Tubingen Institut fur Medizinische Genetik und angewandte Genomik
  • 7h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 165CitationsNumber of citations received by Jonasz Jeremiasz's publications. Updated daily.

About

I am investigating the impact of proteolytic cleavage events on the molecular pathogenesis of different neurodegenerative disorders, including the polyglutamine diseases such as Huntington disease (HD), spinocerebellar ataxia type 17 (SCA17) and spinocerebellar ataxia type 3 (SCA3) aka Machado-Joseph disease (MJD). The main focus of my research is on calpains, a class of calcium-activated proteases, which act as important modulators of multiple cellular functions.

Recent publications

  • Killing Two Angry Birds with One Stone: Autophagy Activation by Inhibiting Calpains in Neurodegenerative Diseases and beyond

    • Weber J
    • Pereira Sena P
    • Singer E
    • et al.
    N/AReaders
    3Citations
  • Olesoxime in neurodegenerative diseases: Scrutinising a promising drug candidate

    • Weber J
    • Clemensson L
    • Schiöth H
    • et al.
    N/AReaders
    N/ACitations

Professional experience

Postdoctoral Researcher

University Hospital Tübingen Department fo Medical Genetics and Applied Genomics

September 2017 - Present

PhD student / researcher

University Hospital Tübingen Department fo Medical Genetics and Applied Genomics

August 2011 - August 2017(6 years)

Education

Institute of Medical Genetics and Applied Genomics

University of Tübingen

August 2011 - September 2017(6 years)